Hippo Protocol

Hippo Protocol (HP) presents a contrast between a strong, high-utility conceptual framework and weak technical and economic execution. The project scores highest in 'Market and Use Case' (7.2/10), driven by its ambitious goal to solve healthcare data fragmentation using Zero-Knowledge Proofs and a sovereign Layer 1 blockchain. However, the project's foundation is compromised by critically low 'Active Development' (3.5/10), characterized by a lack of engineering velocity and community contributions. 'Tokenomics' (5.5/10) poses a specific risk for investors due to a high inflation rate (~25% in Year 1) aimed at bootstrapping the network, which likely creates sustained sell pressure. While the team has operational longevity since 2018, the absence of a top-tier public security audit for the new mainnet and the reliance on administrative rather than technical milestones suggest significant structural risks. Consequently, HP represents a niche infrastructure play that relies heavily on institutional healthcare adoption to overcome its inflationary and developmental hurdles.